Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Common Equity: 2014-2025

Historic Common Equity for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $3.1 billion.

  • Surgery Partners' Common Equity rose 96.73% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 96.73%. This contributed to the annual value of $3.2 billion for FY2024, which is 533.53% up from last year.
  • Surgery Partners' Common Equity amounted to $3.1 billion in Q3 2025, which was up 96.73% from $3.2 billion recorded in Q2 2025.
  • Surgery Partners' 5-year Common Equity high stood at $3.2 billion for Q4 2024, and its period low was $1.1 billion during Q1 2021.
  • Moreover, its 5-year median value for Common Equity was $3.0 billion (2023), whereas its average is $2.6 billion.
  • Per our database at Business Quant, Surgery Partners' Common Equity surged by 12328.53% in 2021 and then crashed by 62.34% in 2025.
  • Surgery Partners' Common Equity (Quarter) stood at $2.0 billion in 2021, then skyrocketed by 49.31% to $2.9 billion in 2022, then rose by 3.18% to $3.0 billion in 2023, then rose by 5.34% to $3.2 billion in 2024, then decreased by 1.7% to $3.1 billion in 2025.
  • Its Common Equity was $3.1 billion in Q3 2025, compared to $3.2 billion in Q2 2025 and $3.2 billion in Q1 2025.